GlassScriptPhysician profile
Lauren Davis
NPI 1891134227
$1,063.39
in general payments reported to CMS, 2019-2025
15 companies · $712 in 2025
The $712 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.92 · 2020: $14.26 · 2021: $72.56 · 2022: $83.82 · 2023: $84.36 · 2024: $64.35 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $679 · Food and Beverage: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $679.19 |
| Food and Beverage | $181.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $717.37 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $62.44 | 2023-2024 | Myfembree |
| Coopersurgical, INC. | $36.35 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $32.93 | 2025 | |
| Abbvie INC. | $30.62 | 2019-2020 | |
| Ethicon US, LLC | $29.04 | 2021 | |
| Glaxosmithkline, LLC. | $21.44 | 2023 | Trelegy Ellipta |
| Exeltis, USA INC. | $21.02 | 2024 | Slynd |
| Evofem Biosciences, INC. | $18.55 | 2021 | |
| Meditrina | $18.44 | 2023 | |
| Hologic Sales and Service, LLC | $17.62 | 2022 | |
| Amag Pharmaceuticals, INC. | $15.56 | 2019 | |
| Organon LLC | $14.90 | 2022-2024 | |
| Gynesonics, INC. | $14.77 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Therapeuticsmd, INC. | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.